未找到相关数据
Tislelizumab plus cisplatin/carboplatin and gemcitabine versus placebo plus cisplatin/carboplatin and gemcitabine in Chinese patients with advanced urothelial carcinoma: A phase III trial in progress
被引：0
作者：
Bi, Feng
Li, Han-Zhong
Zhu, Shaoxing
Zou, Qing
Tang, Jia
Zhang, Wei
Ye, Dingwei
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[2] Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[4] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
[5] BeiGene Shanghai Co Ltd, Shanghai, Peoples R China
[6] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai, Peoples R China
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS588
引用
收藏
页数：2
相关论文